Supernus ADHD drug is FDA approved; first new ‘non-stimulant’ med in a decade
Supernus ADHD drug is FDA approved; first new ‘non-stimulant’ med in a decade
FDA approval of Supernus Pharmaceuticals drug Qelbree gives attention-deficit hyperactivity disorder patients another treatment option that is not classified as a Schedule II substance. It’s a different formulation of a drug that was first approved in Europe decades ago.
Shares0
Attention-deficit hyperactivity disorder (ADHD) can be addressed by several medicines already commercially available but there’s now another treatment option and it’s the first new FDA-approved drug of its type in more than a decade.
MedCity News
How to overcome AI’s healthcare headwinds
AI has already shown tremendous promise for everything from automating patient communication and non-clinical administrative tasks to reducing physician burnout. But realizing that promise more broadly requires AI developers to establish trust with their healthcare users.
Shares0
The bloom may be off the rose when it comes to the use of AI in healthcare, as multiple missteps have cast doubt on whether the technology can deliver real change for the industry. IBM’s recent decision to spin off Watson Health demonstrates just how difficult it can be to apply AI to some of healthcare’s trickiest challenges–and how easy it is to create cynicism among would-be users. AI efforts also have been tainted by biased datasets, creating tools that perpetuate inequality. Even some useful AI tools, like hospice software that helps caregivers maximize facetime with their sickest patients, have caused frustration and confusion when re
MedCity News
Digital health companies raised $6.7B, breaking a record for Q1
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
Shares1
The seemingly-constant stream of funding announcements in March drove digital health funding to a new record.
Startups raised $6.7 billion across 147 deals in the first quarter, according to a new report by Rock Health. And they’ve been raising rounds at a much faster pace than previous years.
Much of the activity was driven by large, so-called “mega-deals” of $100 million and up. This helped prop up the average deal size from $31.7 million last year to $45.9 million so far in 2021.
Get the latest industry news first when you subscribe to our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
MedCity News
Dear President Biden: A Healthcare interoperability wishlist for 2021
Your administration needs to establish a mandate requiring health systems that have data sharing capabilities to share their Covid-19 data in the next eight months. This includes Covid-19 test results, vaccination information, and other critical data.
Shares0
Dear President Biden,
I know you have a very full agenda and several initiatives you plan to achieve early in your term, including ensuring enough Covid-19 vaccinations are available for all eligible Americans by the end of May, and a pledge to return to a semblance of normalcy by July 4. Those are lofty goals that will require seamless coordination between the drug manufacturers, vaccine supply chain, and the delivery side of the health system. The initial rollout of the Covid-19 vaccine in the U.S. has had its fair share of setbacks, but the widespread rollout to the general population will depend on our ability to provide actionable data